260 related articles for article (PubMed ID: 12630704)
1. 2,3-Butanedione monoxime (BDM) as a myosin inhibitor.
Ostap EM
J Muscle Res Cell Motil; 2002; 23(4):305-8. PubMed ID: 12630704
[TBL] [Abstract][Full Text] [Related]
2. BDM (2,3-butanedione monoxime), an inhibitor of myosin-actin interaction, suppresses myofibrillogenesis in skeletal muscle cells in culture.
Soeno Y; Shimada Y; Obinata T
Cell Tissue Res; 1999 Feb; 295(2):307-16. PubMed ID: 9931377
[TBL] [Abstract][Full Text] [Related]
3. The influence of 2,3-butanedione 2-monoxime (BDM) on the interaction between actin and myosin in solution and in skinned muscle fibres.
McKillop DF; Fortune NS; Ranatunga KW; Geeves MA
J Muscle Res Cell Motil; 1994 Jun; 15(3):309-18. PubMed ID: 7929796
[TBL] [Abstract][Full Text] [Related]
4. Does 2,3-butanedione monoxime inhibit nonmuscle myosin?
Forer A; Fabian L
Protoplasma; 2005 Apr; 225(1-2):1-4. PubMed ID: 15868207
[TBL] [Abstract][Full Text] [Related]
5. The myosin ATPase inhibitor 2,3-butanedione-2-monoxime disorganizes microtubules as well as F-actin in Saccharomyces cerevisiae.
Chon K; Hwang HS; Lee JH; Song K
Cell Biol Toxicol; 2001; 17(6):383-93. PubMed ID: 11787860
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle myosin cross-bridge cycling is necessary for myofibrillogenesis.
Ramachandran I; Terry M; Ferrari MB
Cell Motil Cytoskeleton; 2003 May; 55(1):61-72. PubMed ID: 12673599
[TBL] [Abstract][Full Text] [Related]
7. [Non-specific effect of myosin inhibitor BDM on skeletal muscle contractile function].
Yu ZB; Gao F
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Nov; 21(4):449-52. PubMed ID: 21180172
[TBL] [Abstract][Full Text] [Related]
8. Effects of myosin ATPase inhibitor 2,3-butanedione 2-monoxime on distributions of myosins, F-actin, microtubules, and cortical endoplasmic reticulum in maize root apices.
Samaj J; Peters M; Volkmann D; Baluska F
Plant Cell Physiol; 2000 May; 41(5):571-82. PubMed ID: 10929940
[TBL] [Abstract][Full Text] [Related]
9. The myosin ATPase inhibitor, 2,3-butanedione 2-monoxime, prevents protein secretion by the basidiomycete Coprinopsis cinerea.
Hashimoto K; Yokota E; Shimmen T; Yoshida M
Biotechnol Lett; 2011 Apr; 33(4):769-75. PubMed ID: 21165671
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of 2,3-butanedione monoxime on force production, myosin light chain phosphorylation and chemical energy usage in intact and permeabilized smooth and skeletal muscles.
Siegman MJ; Mooers SU; Warren TB; Warshaw DM; Ikebe M; Butler TM
J Muscle Res Cell Motil; 1994 Aug; 15(4):457-72. PubMed ID: 7806639
[TBL] [Abstract][Full Text] [Related]
11. Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation.
Dhawan J; Helfman DM
J Cell Sci; 2004 Aug; 117(Pt 17):3735-48. PubMed ID: 15252113
[TBL] [Abstract][Full Text] [Related]
12. Butanedione monoxime suppresses contraction and ATPase activity of rabbit skeletal muscle.
Higuchi H; Takemori S
J Biochem; 1989 Apr; 105(4):638-43. PubMed ID: 2527229
[TBL] [Abstract][Full Text] [Related]
13. Interplay of troponin- and Myosin-based pathways of calcium activation in skeletal and cardiac muscle: the use of W7 as an inhibitor of thin filament activation.
Adhikari BB; Wang K
Biophys J; 2004 Jan; 86(1 Pt 1):359-70. PubMed ID: 14695278
[TBL] [Abstract][Full Text] [Related]
14. Effect of 2,3-butanedione monoxime on myosin and myofibrillar ATPases. An example of an uncompetitive inhibitor.
Herrmann C; Wray J; Travers F; Barman T
Biochemistry; 1992 Dec; 31(48):12227-32. PubMed ID: 1457420
[TBL] [Abstract][Full Text] [Related]
15. Effects of the myosin inhibitor 2,3-butanedione monoxime on the physiology of fission yeast.
Steinberg G; McIntosh JR
Eur J Cell Biol; 1998 Dec; 77(4):284-93. PubMed ID: 9930653
[TBL] [Abstract][Full Text] [Related]
16. Modulation of IP(3)-sensitive Ca(2+) release by 2,3-butanedione monoxime.
Turvey MR; Laude AJ; Ives EO; Seager WH; Taylor CW; Thorn P
Pflugers Arch; 2003 Feb; 445(5):614-21. PubMed ID: 12634934
[TBL] [Abstract][Full Text] [Related]
17. The myosin ATPase inhibitor 2,3-butanedione-2-monoxime (BDM) inhibits tip growth and cytokinesis in the fission yeast, Schizosaccharomyces pombe.
May KM; Wheatley SP; Amin V; Hyams JS
Cell Motil Cytoskeleton; 1998; 41(2):117-25. PubMed ID: 9786087
[TBL] [Abstract][Full Text] [Related]
18. The motility of Chara corallina myosin was inhibited reversibly by 2,3-butanedione monoxime (BDM).
Funaki K; Nagata A; Akimoto Y; Shimada K; Ito K; Yamamoto K
Plant Cell Physiol; 2004 Sep; 45(9):1342-5. PubMed ID: 15509860
[TBL] [Abstract][Full Text] [Related]
19. 2,3-Butandione 2-monoxime inhibits skeletal myosin II by accelerating ATP cleavage.
Komatsu H; Koseki Y; Kanno T; Aoki S; Kodama T
Biochem Biophys Res Commun; 2017 Aug; 490(3):849-854. PubMed ID: 28648599
[TBL] [Abstract][Full Text] [Related]
20. 2,3-butanedione monoxime (BDM), a potent inhibitor of actin-myosin interaction, induces ion and fluid transport in MDCK monolayers.
Castillo AM; Reyes JL; Sánchez E; Mondragón R; Meza I
J Muscle Res Cell Motil; 2002; 23(3):223-34. PubMed ID: 12500902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]